Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Entera Bio, Ltd. (the "Issuer")
13G
ENTX · M40527109
|
4.1% |
8/4/2026
Event 7/28/2026
|
|||
| Seven Fleet Horizon Master Fund LP | 1.1% | ||||
| Seven Fleet Master Fund LP | 3.0% | ||||
| Seven Fleet Capital Management LP | 4.1% | ||||
| Seven Fleet Capital Management GP LLC | 4.1% | ||||
| Brian Liu | 4.1% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 2
CTMX · 23284F105
|
0.5% |
5/15/2026
Event 3/31/2026
|
|||
| Seven Fleet Master Fund LP | 0.5% | ||||
| Seven Fleet Capital Management LP | 0.5% | ||||
| Seven Fleet Capital Management GP LLC | 0.5% | ||||
| Brian Liu | 0.5% | ||||
|
Veradermics, Inc
13D
MANE · 922967104
|
0.2% |
5/5/2026
Event 5/1/2026
|
|||
| Seven Fleet Master Fund LP | 0.2% | ||||
| Seven Fleet Capital Management LP | 0.2% | ||||
| Seven Fleet Capital Management GP LLC | 0.2% | ||||
| Brian Liu | 0.2% | ||||
|
CytomX Therapeutics, Inc.
13G/A
Amendment 1
CTMX · 23284F105
|
<0.1% |
11/14/2025
Event 9/30/2025
|
|||
| Seven Fleet Master Fund LP | <0.1% | ||||
| Seven Fleet Capital Management LP | <0.1% | ||||
| Seven Fleet Capital Management GP LLC | <0.1% | ||||
| Brian Liu | <0.1% | ||||
|
CG Oncology, Inc.
13D/A
Amendment 1
CGON · 156944100
|
2.0% |
10/28/2025
Event 10/6/2025
|
|||
| Seven Fleet Master Fund LP | 1.9% | ||||
| Seven Fleet Capital Management LP | 1.9% | ||||
| Seven Fleet Capital Management GP LLC | 1.9% | ||||
| Brian Liu | 2.0% | ||||